In the wake of the Supreme Court’s Dobbs ruling that ended federal abortion rights, abortion providers easily circumvented red-state restrictions by mailing pills that starve and suffocate a fetus directly to women or potentially partners who could secretly drug them, a practice now temporarily reinstated by Supreme Court Justice Samuel Alito.Providers of so-called gender-affirming care for young people are doing the same with testosterone, “unopposed” estrogen, puberty blockers, anti-androgens and dihydrotestosterone (DHT) blockers, circumventing state Medicaid restrictions and lying to insurance companies by misrepresenting the purpose of the treatments, according to a new report.
The World Professional Association for Transgender Health, Campaign for Southern Equality, Planned Parenthood and QueerDoc have “publicly promoted the use of non-F64 diagnosis codes” – those not intended to code gender-identity disorders – to perform “sex-denying” procedures on children, medical advocacy group Do No Harm alleges.
“By framing these practices under conventional endocrinology or other non-F64 medical diagnoses, providers, at a minimum, circumvent official coding guidelines and ethical billing standards” if not commit insurance fraud and violate state laws restricting Medicaid funding for pediatric medicalized gender transitions or the procedures themselves, the report says.
None of the groups flagged by Do No Harm answered Just the News queries for their response to the allegations, which are backed by live and archived versions of their own webpages.
The Justice Department is seeking judicial relief to continue probing healthcare providers for evidence of such insurance billing fraud, “misrepresenting a patient’s sex in medical records” and fraudulently diagnosing gender dysphoria so insurers will cover off-label prescriptions of cross-sex hormones and puberty blockers.
The department asked the 4th U.S. Circuit Court of Appeals last week to overturn a lower court that quashed its July 2025 subpoena to Children’s National Hospital, in Washington, D.C., which paused pharmaceutical gender transitions right after President Trump’s executive order against such youth treatments and permanently ended them two months after the subpoena.
U.S. District Judge Julie Rubin, nominated by Democrat President Joe Biden, “misunderstood the legal standard and largely ignored the government’s explanation of relevance,” while wrongly “relying on [her] assessment of the ‘policy objective’ of the administration,” DOJ said.
Rubin, before her 2022 confirmation, faced interrogation on abortion and gender identity by then-Senate Judiciary Committee Ranking Republican Chuck Grassley.
DOJ is also trying to resurrect its subpoena for QueerDoc – a self-described ‘Trans Online Doctor’s Office’ – that was quashed last fall by another Biden nominee, U.S. District Judge Jamal Whitehead, better known for ordering the administration to admit 12,000 refugees a year ago.
The 9th Circuit heard oral argument in March but has not ruled yet. DOJ’s January reply brief argued Whitehead wrongly quashed the subpoena “based on an ostensible improper subjective purpose,” a novel “heightened standard” which he should have at least let the government try to satisfy.”
